Search

A study conducted at Fudan University in Shanghai, China has developed a non-invasive method for diagnosing liver fibrosis using targeted gadolinium-based nanoparticles. Liver fibrosis is a condition that can lead to cirrhosis and liver tumors, so accurate diagnosis is crucial. The researchers created hyaluronic acid-coated nanoprobes that specifically target hepatic stellate cells with elevated CD44 expression, which are associated with liver fibrosis. These nanoprobes were found to effectively target the cells and produce high-quality MRI images, allowing for efficient diagnosis of liver fibrosis. [Extracted from the article]

A study conducted at Sun Yat-Sen University has developed a new method for personalized treatment of hypertension. The researchers created activatable renin nanoprobes (ARNs) that can detect renin activity in the body, allowing for accurate profiling and guiding of antihypertensive therapy. The ARNs were found to outperform the gold standard radioimmunoassay in detecting renin levels. The researchers believe that this nanoprobe platform has the potential to improve outcomes for hypertensive patients by assisting clinicians in rapidly and accurately classifying patients and selecting tailored treatments. [Extracted from the article]

Researchers from Federal University Pernambuco in Recife, Brazil have developed bimodal nanoprobes for imaging techniques by combining quantum dots (QDs) with paramagnetic complexes (GdDOTA). These nanoprobes showed enhanced emission intensity compared to bare QDs and exhibited higher r1 values than clinical GdDOTA. The bimodal systems demonstrated promising performance for both optical and magnetic resonance imaging, making them potential contrast agents. This research was funded by various organizations and has been peer-reviewed. [Extracted from the article]

The article focuses on a Phase 2 multicenter trial conducted at the University of Pennsylvania, evaluating the use of a pH-activatable nanoprobe for intraoperative molecular imaging of lung cancer. Topics include the efficacy of the nanoprobe in detecting tumors during surgery, the comparison of imaging results with traditional methods, and the safety and clinical impact of the technology.

Researchers at Soochow University in Suzhou, China have developed a multifunctional nanoagent for bladder cancer downstaging and bladder-preserving therapy. The nanoagent, which is a nanoprobe labeled with Lu-177, was able to target and image both nonmuscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) after being instilled into the bladder. The study showed that the nanoprobe was effective in downstaging the cancer and inhibiting metastasis, demonstrating its potential for bladder preservation in bladder cancer treatment. The research was supported by the National Natural Science Foundation of China and the National Key Research and Development Program of China. [Extracted from the article]

Researchers from Xi'an Jiaotong University in China have developed a new nitroreductase-responsive nanoprobe called NanoBodipy for non-invasive tumor imaging and intraoperative guidance. The nanoprobe, which has a homogeneous composition and high loading capacity, can efficiently accumulate in tumors and be activated by overexpressed nitroreductase in tumor cells. The researchers successfully performed complete tumor resection surgery using the real-time fluorescence guidance provided by NanoBodipy. This research has been peer-reviewed and published in Chinese Chemical Letters. [Extracted from the article]

Researchers at the Federal University of Pernambuco in Brazil have developed bimodal nanoprobes for diagnostic magnetic resonance imaging (MRI) and optical imaging. The nanoprobes, which consist of AgInSe quantum dots and gadolinium complexes, showed good optical properties and higher relaxivity compared to clinically used contrast agents. The researchers concluded that these nanoprobes have the potential to be used as contrast agents for MRI and optical imaging. This information is available in a journal article published by MDPI AG. [Extracted from the article]

Researchers at Anhui Normal University in Wuhu, China have developed a new nanoprobe called LyNO-Pdots that can be used for ratiometric imaging of lysosomal nitric oxide (NO) variations in brain cells and tissues. The probe showed high specificity, stability, and good penetration through the blood-brain barrier. In their study, the researchers found that the NO content in the brains of mice with Alzheimer's disease was significantly higher than in normal mice. This research was supported by the National Natural Science Foundation of China and has been peer-reviewed. [Extracted from the article]

A study conducted by researchers at Xuzhou Medical University in China has developed a new intelligent nanoprobe called GHPSM that shows potential for monitoring and delaying the progression of osteoarthritis (OA). The nanoprobe is designed to target the OA microenvironment and reshape it by reducing inflammation and oxidative stress, increasing the expression of structural proteins, and reducing cartilage degradation and chondrocyte apoptosis. The researchers successfully tracked the progression of early OA disease using fluorescence/MR imaging and X-ray imaging of the knee joint. These findings provide novel ideas for future research in OA diagnosis and treatment. [Extracted from the article]

A recent study conducted by researchers at Shanghai Jiao Tong University in China has developed a new type of nanoprobes for ultra-high-field magnetic resonance imaging (MRI) of isolated tumor cells (ITCs). The conventional approach to diagnosing ITCs through invasive biopsies is risky and can lead to overdiagnosis and overtreatment. The new nanoprobes, called structural defect-enabled magnetic neutrality nanoprobe (MNN), have an exceptionally low magnetic susceptibility, which mitigates the T2-decaying effect and enhances the UHF T1 contrast. Under 9 T MRI, the MNNs demonstrated a high-performance imaging capability, allowing for the noninvasive visualization of ITCs with a detection threshold of approximately 0.16 mm. This advancement in UHF-MRI has significant implications for diagnostic purposes and metastasis research. [Extracted from the article]

A study conducted by researchers at Hefei University of Technology in China has reported new findings in the field of nanoprobes. The study focuses on the preparation of near-infrared-II (NIR-II) polymer nanoprobes through twisted intramolecular charge transfer and Förster resonance energy transfer of NIR-I dye. The researchers synthesized stable small-sized polymer NIR-II fluoroprobes that enhance NIR-II emission and provide high-resolution angiography. The fluorophore shows potential applications in the prognosis of kidney diseases and can be rapidly excreted from the kidney. The study concludes that the probes with rapid renal clearance can be used for angiography, imaging of middle cerebral artery occlusion mice, and prognosis of acute kidney injury mice. [Extracted from the article]

Researchers from Beijing University of Technology have developed a new method for diagnosing inflammatory liver disease (ILD) using liver-targeted ionizable lipid nanoparticles (iLNPs) and fluorogenic probes. The iLNPs enhance the accumulation of the probes in the liver and enable high-precision detection of oxidative stress in hepatocytes. This innovative approach has shown promise in accurately diagnosing ILD at early stages. The study was funded by various organizations in China and has been peer-reviewed. [Extracted from the article]

Researchers from Liaocheng University in the People's Republic of China have developed a novel method for imaging multiple DNA repair enzymes in living cells. The researchers constructed a framework nucleic acids (FNAs) fluorescent nanoprobe that can detect the activity of uracil DNA glycosylase (UDG) and human apurinic/apyrimidinic endonuclease 1 (APE1), two important DNA repair enzymes. The nanoprobe exhibited good sensitivity and selectivity for UDG and APE1, and it had little toxicity to normal and cancer cells. This research provides a new strategy for imaging DNA repair enzymes and has potential applications in biological research and clinical diagnosis. [Extracted from the article]

A study conducted at the Affiliated Hospital of Southwest Medical University in China has explored the synthesis of fluorescent nanoprobes for imaging lung inflammation and diseased tissues. The researchers used various reagents to synthesize the nanoprobes and conducted experiments using human lung cells. They found that the iron oxide nanoprobes had the highest fluorescence intensity, while Cy5.5 and RFP nanoprobes also showed high fluorescence intensity. The study suggests that fluorescent nanoprobes have potential as a non-invasive and sensitive tool for imaging lung inflammation and diseased tissue. For more information, readers can refer to the Journal of Biomedical Nanotechnology. [Extracted from the article]

A recent report from Shanghai Jiao Tong University in China discusses the development of a new nanoprobe for magnetic resonance imaging (MRI) of tumor apoptosis. The nanoprobe, called Gd-6-ZnDPA, consists of a hexanuclear gadolinium nanocluster with an apoptosis-targeting group. This nanoprobe has shown promising results in tumor-bearing mice, with an enhanced MR signal ratio and a long MRI imaging acquisition time window. The researchers believe that this experimental gadolinium-based contrast agent has potential for imaging tumor apoptosis using MRI. [Extracted from the article]

A report from Fudan University in Shanghai, China discusses the use of nanoprobes in magnetic resonance imaging (MRI) for the early diagnosis of brain diseases. MRI is currently used for brain disease diagnosis, but there is a need for improved differentiation between healthy and diseased tissue. Nanomaterials offer a potential solution by allowing the construction of functional MRI nanoprobes with high specificity and sensitivity. The report summarizes the progress in engineering nanoprobes for MRI of brain diseases, including probe types, design, and applications. The challenges and future prospects of MRI nanoprobes are also discussed. [Extracted from the article]

A study conducted at Hefei University of Technology in China explores the use of multifunctional nanoprobes for sensing and imaging the pathophysiological processes of cancer cells. The researchers highlight the importance of medical imaging technologies in studying cancer and their ability to provide high-resolution and high-contrast images for precise diagnostics. The nanoprobes discussed in the study have been evaluated both in vitro and in vivo, and they offer potential for selective imaging of cancer cells through various cellular metabolism pathways. The researchers anticipate that this review will inspire new ideas for imaging cancer cells and contribute to advancements in cancer therapies and drug research. [Extracted from the article]

Researchers from the First Hospital of Jilin University in Changchun, China have developed biodegradable near-infrared-II (NIR-II) rare-earth nanoprobes for enhanced neural imaging. These nanoprobes have long wavelength emission, high quantum yield, and tunable biodegradation time in vivo. They improve imaging depth and resolution in a mouse model of neural activity, allowing for a better understanding of the structure and function of the nervous system. The biodegradability of these nanoprobes ensures minimal long-term toxicity and enables repeated monitoring of damaged nerves during the recovery or deterioration process. This research has been peer-reviewed and may have implications for neuroscience research and clinical diagnostics. [Extracted from the article]

Researchers at the School of Science and Engineering have developed a new theranostic agent for the treatment of gliomas, a type of brain tumor. The agent combines aggregation-induced emission (AIE) photosensitizers with rare-earth doping nanoparticles (RENPs) and is decorated with a D-type neuropeptide for targeted delivery to the tumor. Under near-infrared (NIR) light irradiation, the agent produces reactive oxygen species to inhibit tumor growth. This study suggests that this multifunctional agent could be a promising candidate for non-invasive treatment of brain tumors. [Extracted from the article]

A study conducted at Qingdao University in Shandong, China, explores the use of dual-emitting fluorescence ratiometric nanoprobes (FRNPs) in various applications. FRNPs have the ability to detect in-vitro/in-vivo pH levels and have been extensively used in pH sensing, imaging, and therapeutic applications. The study provides a comprehensive review of the construction methods, applications, and future prospects of FRNPs-pH systems. The research concludes that this review will contribute to the development of luminescent nanoprobes and sensing materials for biomedical applications. [Extracted from the article]

Researchers at Fudan University in Shanghai, China have developed a new nanoprobe called ANG-PEG-UCNP that can cross the blood-cerebrospinal fluid (B-CSF) barrier. The B-CSF barrier plays a crucial role in maintaining homeostasis in the central nervous system by preventing the entry of harmful substances into the brain. This nanoprobe has the potential to enhance medication penetration into the brain and could be used for noninvasive magnetic resonance ventriculography to accurately define the ventricular anatomy and locate sites of cerebrospinal fluid obstruction. The study was funded by the National Natural Science Foundation of China and the Natural Science Basic Research Plan of Shanxi. [Extracted from the article]

A recent study conducted by investigators from Southeast University in Nanjing, China, explores the use of nanoelectronics in monitoring intracellular glutathione (GSH) depletion. GSH is an important antioxidant in cells, and its depletion can disrupt the redox balance. The researchers propose a method that utilizes high concentrations of GSH in the tumor microenvironment to trigger a redox reaction of Cu(II) and generate copper nanoprobes with fluorescence and tumor growth inhibition properties. The study also discusses the use of a carbon micro-nano electrode to construct a single-cell sensing platform for detecting GSH content in living cells. This research provides valuable insights into the detection of single-cell biomolecules and has been peer-reviewed. [Extracted from the article]

Researchers from Weill Cornell Medicine have developed a new nanotechnology called D3, which is a near infrared fluorogenic nanoprobe that can detect and image cellular senescence in real-time. Senescence is a cell-cycle arrest state that can impact aging and cancer. The D3 nanoprobe is activated by highly elevated levels of reactive oxygen species (ROS), which are critical for the induction and maintenance of senescence. When injected into senescent tumor-bearing mice, the D3 nanoprobe accumulates in tumors and its fluorescence signal is turned on specifically by senescence-associated ROS. This groundbreaking design provides a powerful imaging tool to identify and assess cellular senescence in living organisms. [Extracted from the article]

A recent report from Shangqiu Medical College in China discusses the use of DNA nanomaterials for fluorescence imaging on cell membranes. The researchers highlight the importance of visualizing and monitoring biomolecules associated with cell membranes and disease markers in order to understand the biological functions of cell membranes and track disease progression. The article explores the conditions for imaging DNA nanomaterials in the cell membrane microenvironment and summarizes the imaging applications of cell membrane receptors and other molecules. The researchers also discuss the challenges and difficulties associated with using DNA nanomaterials for cell membrane imaging. This research provides valuable insights into the potential of DNA-based fluorescent nanoprobe technology for cancer cell membrane imaging. [Extracted from the article]

A recent study conducted at the First Affiliated Hospital of Kunming Medical University explored the role of mesothelin (MSLN) in the migration, invasion, and prognosis of malignant pleural mesothelioma (MPM). The researchers developed an MRI nanoprobe that targets MSLN to assess its status in vitro and in vivo. They found that MSLN expression was higher in the epithelial type of MPM and increased with tumor growth. The study concluded that this method could potentially aid in the early detection, histological subtype identification, and assessment of migration, invasion, and prognosis in MPM. [Extracted from the article]

Researchers at Fudan University in Fuzhou, China have developed a novel dual-modal imaging probe for the accurate monitoring of hydrogen sulfide (H2S) in colon cancer. H2S has been shown to play a crucial role in tumor growth and proliferation in colon cancer. The probe utilizes a combination of near-infrared fluorescence and photoacoustic imaging to provide "double assurances" for accurate imaging and monitoring of H2S in vivo. This research has been peer-reviewed and offers potential advancements in the diagnosis and treatment of colon cancer. [Extracted from the article]

Researchers at Shandong Normal University in Jinan, China have developed a novel nanoprobe called PCN@FL that can detect and image hypochlorous acid (HClO) and phosphorylation simultaneously. This nanoprobe can be used to monitor the levels of HClO and phosphate in early atherosclerosis, a condition characterized by the buildup of plaque in the arteries. The levels of HClO and phosphorylation were found to be significantly higher in early atherosclerotic mice compared to normal mice. This nanoprobe shows promise as a fluorescent tool for the early assessment of atherosclerotic disease. [Extracted from the article]

Researchers from Wuhan University in China have published a report on the use of nanoprobes in imaging-guided precision oncotherapy. The report highlights the potential of nanoprobes, which are nanomaterials functionalized with specific biomolecules, in tumor imaging, diagnosis, and therapy. The researchers discuss the recent advances in anti-tumor drug delivery, tumor surgical navigation, chemodynamic therapy, and phototherapy using nanoprobes. They also provide a perspective on the future direction of nanoprobes in imaging-guided tumor theranostics. This research has been peer-reviewed and offers valuable insights into the field of nanotechnology in cancer treatment. [Extracted from the article]

A recent report from researchers at Zhengzhou University in China discusses the use of nanoprobes for PET/MRI imaging in personalized medicine. The researchers highlight the limitations of current imaging techniques and propose the rational combination of different modalities to achieve more comprehensive disease information and better personalized treatment strategies. They emphasize the importance of designing and synthesizing bifunctional probes for PET/MRI imaging to improve image quality. The study concludes that nano-sized vesicles have the potential to integrate multiple functional substances into one platform, allowing for the fabrication of multifunctional PET/MRI probes for disease diagnosis and treatment. [Extracted from the article]

A report from Hubei University of Science and Technology in China discusses the use of novel nanomaterials for early-stage cancer diagnosis. The researchers synthesized a new block copolymer and used it to prepare nanoparticles encapsulated with perfluoropentane and salicylic acid. These nanoparticles were found to be biocompatible and exhibited promising dual-mode capabilities for ultrasonography and chemical exchange saturation transfer magnetic resonance imaging (CEST MRI) in enhancing the imaging effect of tumors. Early detection of cancer is crucial for improving patient outcomes and preventing cancer-related death. [Extracted from the article]

Researchers from Fuzhou University in Fujian, China have conducted a study on the use of engineering NIR-II luminescent lanthanide nanoprobes for imaging brain diseases in vivo. The researchers highlight the challenges of noninvasive sensitive diagnosis of brain diseases and the potential of lanthanide nanocrystals with near-infrared II photoluminescence for high-resolution imaging. The study comprehensively reviews the recent development of these nanoprobes for brain disease imaging, including luminescence regulation strategies, design strategies, and tailoring for specific brain diseases. The researchers hope that this review will inspire future engineering of lanthanide nanoprobes for the diagnosis and treatment of brain diseases. [Extracted from the article]

Researchers from Kyung Hee University in Yongin, South Korea have developed a new method for detecting thyroid-stimulating hormone (TSH) using a wavelength-dependent three-dimensional (3D) superlocalization imaging technique. The technique utilizes gold nanoislands (GNIs) and quantum dots (QDs) nanoprobes to isolate and acquire scattered and fluorescent signals within an evanescent field layer. The nanobiosensor demonstrated an excellent detection limit of 90 yoctomoles and a wide linear dynamic range for TSH detection. This research may provide a reliable platform for ultrahigh-sensitive nanobiosensors and early diagnosis of diseases. [Extracted from the article]

Researchers at Shandong Normal University in Jinan, China have developed a biomimetic nanoprobe for precise tumor-targeted imaging and chemotherapy. The nanoprobe, derived from a covalent organic framework (COF), is cloaked with an M1 macrophage cell membrane, allowing it to efficiently target cancer cells and tumor tissues. The nanoprobe's peroxidase-like activity converts intratumoral H2O2 into toxic OH, which enhances the chemotherapy. This research provides a promising approach for the development of biomimetic theranostic nanoprobes for clinical tumor theranostic applications. [Extracted from the article]

A recent study conducted by researchers at Hunan Normal University in Changsha, China, has developed a new nanoplatform for the non-invasive monitoring and visualization of liver fibrosis. The nanoplatform, which combines lanthanide nanorods with a photo-triggered NO releasing molecule, allows for simultaneous diagnosis of liver fibrosis and second near infrared (NIR-II) ratiometric fluorescence imaging of the NO gas-based therapy. The researchers found that the nanoplatform provided a powerful tool for timely detection of the progression and therapeutic effect of liver disease. This research has been peer-reviewed and published in the Chemical Engineering Journal. [Extracted from the article]

A recent study conducted by researchers at South China University of Technology proposes a molecular imaging-based strategy to diagnose depression by visualizing the inflammation associated with the condition. The researchers developed inflammation-targeting MRI nanoprobes that could specifically target inflamed vascular endothelial cells and visualize the spatial distribution of inflammation in the depressed brain. This study is the first to directly visualize the distribution of inflammation in the depressed brain in vivo, providing insights into the biological mechanisms of depression and potentially leading to the development of anti-inflammatory therapies. [Extracted from the article]

Keywords: Seoul; South Korea; Asia; Cancer; Connective Tissue Cells; Emerging Technologies; Health and Medicine; Immunology; Macrophages; Mononuclear Phagocyte System; Myeloid Cells; Nanoparticles; Nanoprobes; Nanotechnology; Oncology; Phagocytes EN Seoul South Korea Asia Cancer Connective Tissue Cells Emerging Technologies Health and Medicine Immunology Macrophages Mononuclear Phagocyte System Myeloid Cells Nanoparticles Nanoprobes Nanotechnology Oncology Phagocytes 1148 1148 1 11/06/23 20231111 NES 231111 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Investigators publish new report on Cancer. Interestingly, exhibiting selective cellular uptake behavior mediated by macrophage scavenger receptor class A (SR-A), the FPR675-labeled DSNPs were shown to discriminate between cancer cells and macrophages and were preferentially taken up by TAMs. [Extracted from the article]

The Raman-active self-assembling bioorthogonal enzyme recognition probe (nanoSABER), images the activity of aggressive tumor-associated enzyme legumain." Keywords: Baltimore; State:Maryland; United States; North and Central America; Emerging Technologies; Enzymes and Coenzymes; Nanoprobes; Nanotechnology EN Baltimore State:Maryland United States North and Central America Emerging Technologies Enzymes and Coenzymes Nanoprobes Nanotechnology 224 224 1 10/24/23 20231028 NES 231028 2023 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- New research on Nanotechnology - Nanoprobes is the subject of a report. Through the integration of substrate-specific for tumor-associated enzyme legumain, unique capabilities of nanoSABER for imaging enzyme activity at molecular, cellular, and tissue levels in combination with machine learning models are shown. [Extracted from the article]

Keywords: Nanjing; People's Republic of China; Asia; Emerging Technologies; Nanoparticles; Nanoprecipitation; Nanoprobes; Nanotechnology EN Nanjing People's Republic of China Asia Emerging Technologies Nanoparticles Nanoprecipitation Nanoprobes Nanotechnology 5969 5969 1 10/03/23 20231003 NES 231003 2023 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Research findings on Nanotechnology - Nanoparticles are discussed in a new report. According to the news editors, the research concluded: "Thus, this work provides an approach to improve the stability and FRET efficiency of afterglow probe and may boost the development of afterglow imaging.". [Extracted from the article]

Keywords: Hangzhou; People's Republic of China; Asia; Basal Ganglia Diseases and Conditions; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Emerging Technologies; Enzymes and Coenzymes; Health and Medicine; Monoamine Oxidase; Movement Disorders; Nanoprobes; Nanotechnology; Nervous System Diseases and Conditions; Neurodegenerative Diseases and Conditions; Oxidase; Oxidoreductases Acting on CH-NH2 Group Donors; Parkinson's Disease; Parkinsonian Disorders EN Hangzhou People's Republic of China Asia Basal Ganglia Diseases and Conditions Brain Diseases and Conditions Central Nervous System Diseases and Conditions Emerging Technologies Enzymes and Coenzymes Health and Medicine Monoamine Oxidase Movement Disorders Nanoprobes Nanotechnology Nervous System Diseases and Conditions Neurodegenerative Diseases and Conditions Oxidase Oxidoreductases Acting on CH-NH2 Group Donors Parkinson's Disease Parkinsonian Disorders 162 162 1 09/25/23 20230929 NES 230929 2023 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Fresh data on Neurodegenerative Diseases and Conditions - Parkinson's Disease are presented in a new report. Moreover, we used NIR-MNP to confirm the role of MAO-B inhibitor in delaying Parkinson's disease (PD) progression in mouse PD models through bioimaging technique in vivo.". [Extracted from the article]

Carbon Nanoparticles, Emerging Technologies, Gadolinium, Lanthanoid Series Elements, Nanoparticles, Nanoprobes, Nanotechnology Keywords: Carbon Nanoparticles; Emerging Technologies; Gadolinium; Lanthanoid Series Elements; Nanoparticles; Nanoprobes; Nanotechnology EN Carbon Nanoparticles Emerging Technologies Gadolinium Lanthanoid Series Elements Nanoparticles Nanoprobes Nanotechnology 6020 6020 1 09/04/23 20230908 NES 230908 2023 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Research findings on nanoparticles are discussed in a new report. [Extracted from the article]

Diagnostics and Screening, Emerging Technologies, Health and Medicine, Imaging Technology, Molecular Imaging, Nanoprobes, Nanotechnology, Technology Keywords: Diagnostics and Screening; Emerging Technologies; Health and Medicine; Imaging Technology; Molecular Imaging; Nanoprobes; Nanotechnology; Technology EN Diagnostics and Screening Emerging Technologies Health and Medicine Imaging Technology Molecular Imaging Nanoprobes Nanotechnology Technology 620 620 1 08/21/23 20230826 NES 230826 2023 AUG 27 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- New research on imaging technology is the subject of a new report. [Extracted from the article]

Keywords: Antineoplastics; Cancer; Carcinomas; Drugs and Therapies; Emerging Technologies; Health and Medicine; Liver Cancer; Multikinase Inhibitors; Nanoprobes; Nanotechnology; Oncology; Pharmaceuticals; Sorafenib Therapy; Tyrosine Kinase Inhibitors; VEGF - VEGFR Inhibitors; VEGFR Inhibitors EN Antineoplastics Cancer Carcinomas Drugs and Therapies Emerging Technologies Health and Medicine Liver Cancer Multikinase Inhibitors Nanoprobes Nanotechnology Oncology Pharmaceuticals Sorafenib Therapy Tyrosine Kinase Inhibitors VEGF - VEGFR Inhibitors VEGFR Inhibitors 528 528 1 08/07/23 20230812 NES 230812 2023 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Current study results on liver cancer have been published. Antineoplastics, Cancer, Carcinomas, Drugs and Therapies, Emerging Technologies, Health and Medicine, Liver Cancer, Multikinase Inhibitors, Nanoprobes, Nanotechnology, Oncology, Pharmaceuticals, Sorafenib Therapy, Tyrosine Kinase Inhibitors, VEGF - VEGFR Inhibitors, VEGFR Inhibitors. [Extracted from the article]

Keywords: Wuhan; People's Republic of China; Asia; Emerging Technologies; Nanoprobes; Nanotechnology EN Wuhan People's Republic of China Asia Emerging Technologies Nanoprobes Nanotechnology 294 294 1 07/24/23 20230729 NES 230729 2023 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- A new study on Nanotechnology - Nanoprobes is now available. Developing tumor-targeting NIR-II fluorescent probes withboth high fluorescence brightness and favorable biocompatibility promotesthe clinical applications of NIR-II fluorescence imaging technology. Our news editors obtained a quote from the research from Wuhan University, "Increased amounts ofCH1055-PEG and nanoprobe modification with GE11 peptides enabled imagingwith high NIR-II fluorescence brightness and enhanced tumor-targetingcapability. [Extracted from the article]

Keywords for this news article include: Tianjin, People's Republic of China, Asia, Emerging Technologies, Nanoprobes, Nanotechnology, Tianjin University. Keywords: Tianjin; People's Republic of China; Asia; Emerging Technologies; Nanoprobes; Nanotechnology EN Tianjin People's Republic of China Asia Emerging Technologies Nanoprobes Nanotechnology 928 928 1 07/24/23 20230729 NES 230729 2023 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Researchers detail new data in Nanotechnology - Nanoprobes. [Extracted from the article]

Keywords: Baltimore; State:Maryland; United States; North and Central America; Emerging Technologies; Enzymes and Coenzymes; Nanoprobes; Nanotechnology EN Baltimore State:Maryland United States North and Central America Emerging Technologies Enzymes and Coenzymes Nanoprobes Nanotechnology 320 320 1 06/12/23 20230617 NES 230617 2023 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Investigators discuss new findings in Nanotechnology - Nanoprobes. Financial supporters for this research include National Institutes of Health (NIH) - USA, NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB), NIH National Cancer Institute (NCI), Air Force Office of Scientific Research (AFOSR), NIH National Institute of General Medical Sciences (NIGMS). [Extracted from the article]

Jinan, People's Republic of China, Asia, Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, Cardiovascular Diseases and Conditions, Emerging Technologies, Health and Medicine, Nanoprobes, Nanotechnology Keywords: Jinan; People's Republic of China; Asia; Arterial Occlusive Diseases; Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases and Conditions; Emerging Technologies; Health and Medicine; Nanoprobes; Nanotechnology EN Jinan People's Republic of China Asia Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Cardiovascular Diseases and Conditions Emerging Technologies Health and Medicine Nanoprobes Nanotechnology 313 313 1 06/12/23 20230617 NES 230617 2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Investigators publish new report on Cardiovascular Diseases and Conditions - Atherosclerosis. [Extracted from the article]

Keywords: Beijing; People's Republic of China; Asia; Emerging Technologies; Health and Medicine; Kidney; Nanoprobes; Nanotechnology; Nephrology EN Beijing People's Republic of China Asia Emerging Technologies Health and Medicine Kidney Nanoprobes Nanotechnology Nephrology 1749 1749 1 06/12/23 20230617 NES 230617 2023 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Data detailed on Nanotechnology - Nanoprobes have been presented. Beijing, People's Republic of China, Asia, Emerging Technologies, Health and Medicine, Kidney, Nanoprobes, Nanotechnology, Nephrology. [Extracted from the article]

Keywords: Shenzhen; People's Republic of China; Asia; Arthritis; Autoimmune Diseases and Conditions; Connective Tissue Cells; Emerging Technologies; Health and Medicine; Immunology; Joint Diseases and Conditions; Macrophages; Mononuclear Phagocyte System; Musculoskeletal Diseases and Conditions; Myeloid Cells; Nanoprobes; Nanotechnology; Phagocytes; Rheumatoid Arthritis EN Shenzhen People's Republic of China Asia Arthritis Autoimmune Diseases and Conditions Connective Tissue Cells Emerging Technologies Health and Medicine Immunology Joint Diseases and Conditions Macrophages Mononuclear Phagocyte System Musculoskeletal Diseases and Conditions Myeloid Cells Nanoprobes Nanotechnology Phagocytes Rheumatoid Arthritis 2896 2896 1 05/22/23 20230526 NES 230526 2023 MAY 26 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- A new study on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is now available. According to news reporting originating from Shenzhen, People's Republic of China, by NewsRx correspondents, research stated, "Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation. [Extracted from the article]